Pharmacokinetics of isoniazid, rifampin,and pyrazinamide in children younger than two years of age with tuberculosis: Evidence for implementation of revised World Health Organization recommendations

Thee S.; Seddon J.A.; Donald P.R.; Seifart H.I.; Werely C.J.; Hesseling A.C.; Rosenkranz B.; Roll S.; Magdorf K.; Schaaf H.S.

Pharmacokinetics of isoniazid, rifampin,and pyrazinamide in children younger than two years of age with tuberculosis: Evidence for implementation of revised World Health Organization recommendations

Date

2011

Authors

Thee S.

Seddon J.A.

Donald P.R.

Seifart H.I.

Werely C.J.

Hesseling A.C.

Rosenkranz B.

Roll S.

Magdorf K.

Schaaf H.S.

Description

Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za

Keywords

be tabs, cotrimoxazole, isoniazid, lamivudine, lopinavir plus ritonavir, pyrazide, pyrazinamide, rifampicin, rimcure, ritonavir, stavudine, unclassified drug, abdominal infection, acetylator phenotype, area under the curve, article, child, clinical article, controlled clinical trial, controlled study, dose response, drug blood level, drug dose comparison, extrapulmonary tuberculosis, female, genotype, human, Human immunodeficiency virus infection, infant, lung tuberculosis, male, maximum plasma concentration, mixed infection, nutritional status, observational study, preschool child, priority journal, prospective study, recommended drug dose, time to maximum plasma concentration, tuberculous meningitis, world health organization

Citation

Antimicrobial Agents and Chemotherapy
55
12
http://www.scopus.com/inward/record.url?eid=2-s2.0-81555201905&partnerID=40&md5=8469a08b4be212c62f012ce8e4d4f7ed